Xin Lang Cai Jing·2025-11-12 10:42Core Viewpoint - YXTT Pharmaceutical Group Co., Ltd. has announced the implementation of a cash management plan utilizing up to 2.5 billion yuan of idle funds to enhance the efficiency of fund usage [1][2]. Group 1: Cash Management Plan - The company approved a cash management plan at the 2024 annual shareholders' meeting on May 21, 2025, allowing the use of up to 2.5 billion yuan of idle funds for investments in fixed-income or capital-preserving floating-return financial products, large certificates of deposit, and time deposits [2]. - The collaboration with Huaxia Bank is a recent step in this cash management initiative, although specific investment amounts and product details were not disclosed [2]. Group 2: Risk Control and Investment Strategy - YXTT emphasizes a low-risk investment strategy, adhering to principles of "standardized operation, risk prevention, and cautious investment" [3]. - The company has established a multi-layered risk control mechanism, including oversight by the financial department, internal audits, and regular checks by independent directors to ensure the safety of funds [3]. Group 3: Normalization of Fund Management - Utilizing idle funds for cash management has become a regular practice for YXTT, reflecting its flexibility and standardization in fund management [4]. - The board believes that low-risk financial management can enhance the overall performance of the company while safeguarding fund security, aligning with the interests of all shareholders [4].